Cumberland Pharmaceuticals CPIX
NASDAQ CPIX
$7.51 -0.32 (-4.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cumberland Pharmaceuticals (CPIX) Liabilities from Discontinued Operations (2025 - 2026)

Updated

Cumberland Pharmaceuticals' Liabilities from Discontinued Operations came in at $2.39 million for Q2 2026.

Analysis

Cumberland Pharmaceuticals (CPIX) Liabilities from Discontinued Operations (2025 - 2026) Analysis & Trends

At the end of FY2025, Cumberland Pharmaceuticals' Liabilities from Discontinued Operations was $2.2 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cumberland Pharmaceuticals 117.32 Mn 75.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.39 Mn
Dec 31, 2025 2.20 Mn
API Access

Cumberland Pharmaceuticals Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=CPIX&period=max&api_key=YOUR_API_KEY